Page last updated: 2024-08-16

ribavirin and bibw 2992

ribavirin has been researched along with bibw 2992 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dunn, LA; Fury, MG; Haque, SS; Ho, AA; Katabi, N; Pfister, DG; Sherman, EJ	1

Trials

1 trial(s) available for ribavirin and bibw 2992

Article	Year
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer. Head & neck, 2018, Volume: 40, Issue:2 Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Ribavirin	2018

Article

Year

Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.

Head & neck, 2018, Volume: 40, Issue:2

Topics: Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Progression-Free Survival; Ribavirin

2018